1. Structural dynamics of receptor recognition and pH-induced dissociation of full-length Clostridioides difficile Toxin B
   Mengqiu Jiang et al, 2022, PLOS Biology CrossRef
2. The Potential of Antibody Technology and Silver Nanoparticles for Enhancing Photodynamic Therapy for Melanoma
   Zaria Malindi et al, 2022, Biomedicines CrossRef
3. CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate
   Neelakshi Mungra et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
4. Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4
   Jitesh Chauhan et al, 2023, Nature Communications CrossRef
5. Molecular dynamics, MMGBSA, and docking studies of natural products conjugated to tumor-targeted peptide for targeting BRAF V600E and MERTK receptors
   Dominic J. Lambo et al, 2023, Molecular Diversity CrossRef
6. Immunohistochemical detection of the chondroitin sulfate proteoglycan 4 protein in primary and metastatic melanoma
   Anna Grossauer et al, 2023, Oncology Letters CrossRef
7. The cytoglobin-dependent transcriptome in melanoma indicates a protective function associated with oxidative stress, inflammation and cancer-associated pathways
   Joey De Backer et al, 2024, Scientific Reports CrossRef
8. Targeting NG2 relieves the resistance of BRAF-mutant thyroid cancer cells to BRAF inhibitors
   Fang Sui et al, 2024, Cellular and Molecular Life Sciences CrossRef
9. Integrated Analysis of Energy Metabolism Signature-Identified Distinct Subtypes of Bladder Urothelial Carcinoma
   Fan Zhang et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
10. CSPG4 involvement in endometrial decidualization contributes to the pathogenesis of preeclampsia
    Tianying Zhang et al, 2024, Biology of Reproduction CrossRef